Contrast-enhanced MR imaging in the indirect monitoring of drug release from an interstitial depot.
Port
R E
RE
Unit Pharmacology of Cancer Treatment, German Cancer Research Center, Heidelberg, Germany. r.port@dkfz.de
Schuster
C
C
Port
C R
CR
Bachert
P
P
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D003287:Contrast Media / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D016903:Drug Monitoring / Q000379:methods*; D019786:Gadolinium DTPA / Q000008:administration & dosage*; D007279:Injections, Subcutaneous; D008081:Liposomes; D008279:Magnetic Resonance Imaging; D051381:Rats; D001084:Vidarabine Phosphate / Q000008:administration & dosage / Q000031:analogs & derivatives*
D000964:Antimetabolites, Antineoplastic; D003287:Contrast Media; D003692:Delayed-Action Preparations; D008081:Liposomes; D001084:Vidarabine Phosphate; C042382:fludarabine phosphate; D019786:Gadolinium DTPA